APA (7th ed.) Citation

JJ, P., Á, P., Á, S., M, V., JC, D., E, P., . . . A, C. (2026). Isotretinoin-Induced Meibomian Gland Dysfunction: Rationale for Proactive Clinical Surveillance. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 42(7), 395. https://doi.org/10.1177/10807683261433772

Chicago Style (17th ed.) Citation

JJ, Prados-Carmona, et al. "Isotretinoin-Induced Meibomian Gland Dysfunction: Rationale for Proactive Clinical Surveillance." Journal of Ocular Pharmacology and Therapeutics : The Official Journal of the Association for Ocular Pharmacology and Therapeutics 42, no. 7 (2026): 395. https://doi.org/10.1177/10807683261433772.

MLA (9th ed.) Citation

JJ, Prados-Carmona, et al. "Isotretinoin-Induced Meibomian Gland Dysfunction: Rationale for Proactive Clinical Surveillance." Journal of Ocular Pharmacology and Therapeutics : The Official Journal of the Association for Ocular Pharmacology and Therapeutics, vol. 42, no. 7, 2026, p. 395, https://doi.org/10.1177/10807683261433772.